Kari Torp

555 total citations
25 papers, 406 citations indexed

About

Kari Torp is a scholar working on Oncology, Pediatrics, Perinatology and Child Health and Public Health, Environmental and Occupational Health. According to data from OpenAlex, Kari Torp has authored 25 papers receiving a total of 406 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Oncology, 7 papers in Pediatrics, Perinatology and Child Health and 7 papers in Public Health, Environmental and Occupational Health. Recurrent topics in Kari Torp's work include Neutropenia and Cancer Infections (9 papers), Acute Lymphoblastic Leukemia research (6 papers) and Childhood Cancer Survivors' Quality of Life (5 papers). Kari Torp is often cited by papers focused on Neutropenia and Cancer Infections (9 papers), Acute Lymphoblastic Leukemia research (6 papers) and Childhood Cancer Survivors' Quality of Life (5 papers). Kari Torp collaborates with scholars based in United States, Norway and Canada. Kari Torp's co-authors include Alix E. Seif, Richard Aplenc, Brian T. Fisher, Yimei Li, Yuan‐Shung Huang, Damian Walker, Marko Kavčič, Rochelle Bagatell, Marijana Vujković and Susan R. Rheingold and has published in prestigious journals such as The Lancet, Journal of Clinical Oncology and Blood.

In The Last Decade

Kari Torp

23 papers receiving 388 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Kari Torp United States 13 160 142 126 100 82 25 406
Marko Kavčič United States 13 137 0.9× 174 1.2× 121 1.0× 85 0.8× 54 0.7× 34 439
Beth A. Kurt United States 8 107 0.7× 80 0.6× 91 0.7× 73 0.7× 44 0.5× 10 415
Jean-Christophe Szelag France 9 140 0.9× 94 0.7× 58 0.5× 147 1.5× 12 0.1× 15 652
N. Germann France 10 50 0.3× 255 1.8× 139 1.1× 226 2.3× 15 0.2× 16 602
Luís Guirado Spain 10 89 0.6× 84 0.6× 169 1.3× 34 0.3× 29 0.4× 19 519
Yumeng Wen United States 13 47 0.3× 51 0.4× 90 0.7× 64 0.6× 32 0.4× 36 519
Ülker Koçak Türkiye 14 92 0.6× 94 0.7× 100 0.8× 92 0.9× 17 0.2× 67 580
Mohammed Malekzadeh United States 14 228 1.4× 46 0.3× 105 0.8× 53 0.5× 11 0.1× 24 662
Abanti Chaudhuri United States 12 41 0.3× 41 0.3× 72 0.6× 96 1.0× 84 1.0× 35 501
G. Mark Baillie United States 15 39 0.2× 58 0.4× 94 0.7× 155 1.6× 29 0.4× 33 517

Countries citing papers authored by Kari Torp

Since Specialization
Citations

This map shows the geographic impact of Kari Torp's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kari Torp with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kari Torp more than expected).

Fields of papers citing papers by Kari Torp

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Kari Torp. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kari Torp. The network helps show where Kari Torp may publish in the future.

Co-authorship network of co-authors of Kari Torp

This figure shows the co-authorship network connecting the top 25 collaborators of Kari Torp. A scholar is included among the top collaborators of Kari Torp based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kari Torp. Kari Torp is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Løkkegaard, Ellen, et al.. (2019). A randomized controlled trial of AMH-based individualized FSH dosing in a GnRH antagonist protocol for IVF. Human Reproduction Open. 2019(1). hoz003–hoz003. 13 indexed citations
2.
3.
Fisher, Brian T., Julia Shaklee Sammons, Yichen Li, et al.. (2014). Variation in Risk of Hospital-Onset Clostridium difficile Infection Across  -Lactam Antibiotics in Children With New-Onset Acute Lymphoblastic Leukemia. Journal of the Pediatric Infectious Diseases Society. 3(4). 329–335. 18 indexed citations
4.
Seif, Alix E., Damian Walker, Yimei Li, et al.. (2014). Dexrazoxane exposure and risk of secondary acute myeloid leukemia in pediatric oncology patients. Pediatric Blood & Cancer. 62(4). 704–709. 57 indexed citations
5.
Maude, Shannon L., Julie C. Fitzgerald, Brian T. Fisher, et al.. (2013). Outcome of Pediatric Acute Myeloid Leukemia Patients Receiving Intensive Care in the United States. Pediatric Critical Care Medicine. 15(2). 112–120. 40 indexed citations
6.
Fisher, Brian T., Marko Kavčič, Yichen Li, et al.. (2013). Antifungal Prophylaxis Associated With Decreased Induction Mortality Rates and Resources Utilized in Children With New-Onset Acute Myeloid Leukemia. Clinical Infectious Diseases. 58(4). 502–508. 16 indexed citations
7.
Kavčič, Marko, Brian T. Fisher, Yimei Li, et al.. (2013). Induction mortality and resource utilization in children treated for acute myeloid leukemia at free‐standing pediatric hospitals in the United States. Cancer. 119(10). 1916–1923. 33 indexed citations
8.
Seif, Alix E., Brian T. Fisher, Yimei Li, et al.. (2013). Patient and hospital factors associated with induction mortality in acute lymphoblastic leukemia. Pediatric Blood & Cancer. 61(5). 846–852. 22 indexed citations
9.
Fisher, Brian T., Yimei Li, Alix E. Seif, et al.. (2013). Zoonotic infections in pediatric patients with acute leukemia. Pediatric Blood & Cancer. 60(12). E160–E162. 3 indexed citations
10.
11.
12.
Kavčič, Marko, Brian T. Fisher, Kari Torp, et al.. (2012). Assembly of a cohort of children treated for acute myeloid leukemia at free‐standing children's hospitals in the United States using an administrative database. Pediatric Blood & Cancer. 60(3). 508–511. 34 indexed citations
13.
Fisher, Brian T., Jeffrey S. Gerber, Kateri H. Leckerman, et al.. (2012). Variation in hospital antibiotic prescribing practices for children with acute lymphoblastic leukemia. Leukemia & lymphoma. 54(8). 1633–1639. 19 indexed citations
14.
Walker, Damian, Yimei Li, Yuan‐Shung Huang, et al.. (2012). Dexrazoxane exposure and risk of secondary acute myeloid leukemia in pediatric cancer patients.. Journal of Clinical Oncology. 30(15_suppl). 1504–1504. 1 indexed citations
15.
Kavčič, Marko, Brian T. Fisher, Jeffrey S. Gerber, et al.. (2012). Variability in Antifungal Use for Pediatric Acute Myeloid Leukemia At Children's Hospitals Across the United States. Blood. 120(21). 4278–4278. 3 indexed citations
16.
Borud, O., J H Strømme, Sverre O. Lie, & Kari Torp. (1978). Aspartylglycosaminuria in Northern Norway in eight patients: Clinical heterogeneity and variations with the diet. Journal of Inherited Metabolic Disease. 1(3). 95–97. 4 indexed citations
17.
Borud, O. & Kari Torp. (1976). ASPARTYLGLYCOSAMINURIA IN NORTHERN NORWAY. The Lancet. 307(7968). 1082–1083. 9 indexed citations
18.
Bahna, Sami L. & Kari Torp. (1975). THE SEX VARIABLE IN CHILDHOOD URINARY‐TRACT INFECTION. Acta Paediatrica. 64(4). 581–586. 5 indexed citations
19.
Torp, Kari, et al.. (1956). Encephalitis and Thrombocytopenic Purpura after Rubella. Archives of Disease in Childhood. 31(160). 470–473. 23 indexed citations
20.
Torp, Kari. (1954). Congenital Valvular Formation of the Posterior Urethra. Acta Paediatrica. 43(2). 192–197.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Marko Kavčič Breakdown of academic impact, for papers by Beth A. Kurt Breakdown of academic impact, for papers by Jean-Christophe Szelag Breakdown of academic impact, for papers by N. Germann Breakdown of academic impact, for papers by Luís Guirado Breakdown of academic impact, for papers by Yumeng Wen Breakdown of academic impact, for papers by Ülker Koçak Breakdown of academic impact, for papers by Mohammed Malekzadeh Breakdown of academic impact, for papers by Abanti Chaudhuri Breakdown of academic impact, for papers by G. Mark Baillie
Rankless by CCL
2026